Clinical Scorecard: Fresh Support for Laser Trabeculoplasty
At a Glance
| Category | Detail |
|---|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Patients with newly diagnosed OHT with IOP of 24 mmHg or more at risk of visual impairment, as per current guidelines. |
| Care Setting |
Key Highlights
- Add citation for the claim about LTP delaying incisional surgery.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
- Regular follow-up every 3-6 months to assess IOP and visual field progression.
Risks
Patient & Prescribing Data
LTP is effective in controlling IOP and may be more beneficial than topical medications, but potential side effects should be discussed.
Clinical Best Practices
- Educate patients on the importance of regular follow-up visits.
References
- Rhee DJ et al. Primary Practice Patterns for the initial management of open-angle glaucoma.
- Gazzard G et al. Laser in Glaucoma and Ocular Hypertension (LiGHT) trial.
- Montesano G et al. Estimating the distribution of true rates of visual field progression in glaucoma.
- Quaranta L et al. Adherence and persistence to medical therapy in glaucoma.
- Davis SA et al. Drop instillation and glaucoma.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
